Compounds > actinium
Page last updated: 2024-08-22

actinium and psma-617

actinium has been researched along with psma-617 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's4 (66.67)2.80

Authors

AuthorsStudies
Bruchertseifer, F; Bulut, OC; Flechsig, P; Giesel, FL; Haberkorn, U; Hein, M; Hohenberger, R; Kratochwil, C; Morgenstern, A; Plinkert, P; Rathke, H1
Al Kandari, F; Marafi, F; Naqvi, SAR; Rasheed, R; Usmani, S1
Das, CK; Kaur, K; Mittal, BR; Parmar, M; Sood, A; Vadi, SK; Vatsa, R1
Beheshti, A; Bruchertseifer, F; D'Alessandria, C; Eiber, M; Feuerecker, B; Gafita, A; Gschwend, JE; Heck, M; Knorr, K; Kratochwil, C; Morgenstern, A; Pickhard, A; Retz, M; Seidl, C; Tauber, R; Weber, WA1
Dumond, ARS; Piert, MR; Rodnick, ME; Scott, PJH1
Gill, HJS; Maheshwari, P; Satapathy, S; Sharma, A; Sood, A1

Other Studies

6 other study(ies) available for actinium and psma-617

ArticleYear
Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing
    European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:1

    Topics: Actinium; Aged; Aged, 80 and over; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Male; Middle Aged; Prednisolone; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Salivary Glands; Surgery, Computer-Assisted; Therapeutic Irrigation; Xerostomia

2019
225Ac Prostate-Specific Membrane Antigen Posttherapy α Imaging: Comparing 2 and 3 Photopeaks.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:5

    Topics: Actinium; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Male; Middle Aged; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiometry; Radiopharmaceuticals; Reference Standards

2019
225Ac-PSMA-617 Radioligand Posttherapy Imaging in Metastatic Castrate-Resistant Prostate Cancer Patient Using 3 Photopeaks.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:6

    Topics: Actinium; Alpha Particles; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Ligands; Male; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant

2020
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA.
    European urology, 2021, Volume: 79, Issue:3

    Topics: Actinium; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Xerostomia

2021
Synthesis of
    Current radiopharmaceuticals, 2022, Volume: 15, Issue:2

    Topics: Actinium; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Male; Prostate-Specific Antigen; Radiopharmaceuticals; Tromethamine

2022
Delayed Nephrotoxicity After 225Ac-PSMA-617 Radioligand Therapy.
    Clinical nuclear medicine, 2022, Jun-01, Volume: 47, Issue:6

    Topics: Actinium; Aged; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome

2022